ProTargetMiner as a proteome signature library of anticancer molecules for functional discovery
Open Access
- 15 December 2019
- journal article
- research article
- Published by Springer Science and Business Media LLC in Nature Communications
- Vol. 10 (1), 1-13
- https://doi.org/10.1038/s41467-019-13582-8
Abstract
Deconvolution of targets and action mechanisms of anticancer compounds is fundamental in drug development. Here, we report on ProTargetMiner as a publicly available expandable proteome signature library of anticancer molecules in cancer cell lines. Based on 287 A549 adenocarcinoma proteomes affected by 56 compounds, the main dataset contains 7,328 proteins and 1,307,859 refined protein-drug pairs. These proteomic signatures cluster by compound targets and action mechanisms. The targets and mechanistic proteins are deconvoluted by partial least square modeling, provided through the website http:// protargetminer.genexplain.com. For 9 molecules representing the most diverse mechanisms and the common cancer cell lines MCF-7, RKO and A549, deep proteome datasets are obtained. Combining data from the three cell lines highlights common drug targets and cells-pecific differences. The database can be easily extended and merged with new compound signatures. ProTargetMiner serves as a chemical proteomics resource for the cancer research community, and can become a valuable tool in drug discovery.Keywords
Funding Information
- Cancerfonden (2016/546, 2017/1081)
This publication has 63 references indexed in Scilit:
- Activation of the AXL kinase causes resistance to EGFR-targeted therapy in lung cancerNature Genetics, 2012
- Drug Target Identification from Protein Dynamics using Quantitative Pathway AnalysisJournal of Proteome Research, 2011
- Andromeda: A Peptide Search Engine Integrated into the MaxQuant EnvironmentJournal of Proteome Research, 2011
- GOrilla: a tool for discovery and visualization of enriched GO terms in ranked gene listsBMC Bioinformatics, 2009
- Dynamic Proteomics of Individual Cancer Cells in Response to a DrugScience, 2008
- MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantificationNature Biotechnology, 2008
- Recurrent design patterns in the feedback regulation of the mammalian signalling networkMolecular Systems Biology, 2008
- The Connectivity Map: Using Gene-Expression Signatures to Connect Small Molecules, Genes, and DiseaseScience, 2006
- Proteasome inhibitors induce a terminal unfolded protein response in multiple myeloma cellsBlood, 2006
- Clinical and biochemical studies of high-dose thymidine treatment in patients with solid tumorsZeitschrift für Krebsforschung und Klinische Onkologie, 1984